Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.19.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance (in shares) at Dec. 31, 2017   19,511,276      
Beginning Balance at Dec. 31, 2017 $ 20,712 $ 20 $ 88,447 $ (67,748) $ (7)
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   184,818      
Stock-based compensation 1,108   1,108    
Sales of common stock, net of offering costs (in shares)   5,714,286      
Sales of common stock, net of offering costs 18,381 $ 6 18,375    
Exercise of warrants (in shares)   15,000      
Exercise of warrants 43   43    
Common stock issued in exchange for warrants   242,913      
Net loss (5,716)     (5,716)  
Foreign currency translation adjustment, net of tax 21       21
Balance (in shares) at Mar. 31, 2018   25,668,293      
Ending Balance at Mar. 31, 2018 34,549 $ 26 107,973 (73,464) 14
Balance (in shares) at Dec. 31, 2017   19,511,276      
Beginning Balance at Dec. 31, 2017 20,712 $ 20 88,447 (67,748) (7)
Increase (Decrease) in Stockholders' Equity          
Net loss (11,668)        
Foreign currency translation adjustment, net of tax (15)        
Balance (in shares) at Jun. 30, 2018   26,898,267      
Ending Balance at Jun. 30, 2018 33,240 $ 27 112,651 (79,416) (22)
Balance (in shares) at Mar. 31, 2018   25,668,293      
Beginning Balance at Mar. 31, 2018 34,549 $ 26 107,973 (73,464) 14
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   293,998      
Stock-based compensation 1,639   1,639    
Sales of common stock, net of offering costs (in shares)   857,142      
Sales of common stock, net of offering costs 2,809 $ 1 2,808    
Exercise of warrants (in shares)   74,142      
Exercise of warrants $ 217   217    
Exercise of stock options (in shares) 4,692        
Exercise of stock options $ 14        
Net loss (5,952)     (5,952)  
Foreign currency translation adjustment, net of tax (36)       (36)
Balance (in shares) at Jun. 30, 2018   26,898,267      
Ending Balance at Jun. 30, 2018 $ 33,240 $ 27 112,651 (79,416) (22)
Balance (in shares) at Dec. 31, 2018 27,391,290 27,391,290      
Beginning Balance at Dec. 31, 2018 $ 22,898 $ 27 115,450 (92,564) (15)
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   116,997      
Stock-based compensation 1,040   1,040    
Exercise of warrants (in shares)   140,000      
Exercise of warrants 400 $ 0 400    
Net loss (7,137)     (7,137)  
Foreign currency translation adjustment, net of tax (10)       (10)
Balance (in shares) at Mar. 31, 2019   27,648,287      
Ending Balance at Mar. 31, 2019 $ 17,191 $ 27 116,890 (99,701) (25)
Balance (in shares) at Dec. 31, 2018 27,391,290 27,391,290      
Beginning Balance at Dec. 31, 2018 $ 22,898 $ 27 115,450 (92,564) (15)
Increase (Decrease) in Stockholders' Equity          
Sales of common stock, net of offering costs (in shares) 0        
Net loss $ (14,635)        
Foreign currency translation adjustment, net of tax $ 6        
Balance (in shares) at Jun. 30, 2019 28,329,870 28,329,870      
Ending Balance at Jun. 30, 2019 $ 12,156 $ 28 119,336 (107,199) (9)
Balance (in shares) at Mar. 31, 2019   27,648,287      
Beginning Balance at Mar. 31, 2019 17,191 $ 27 116,890 (99,701) (25)
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   334,774      
Stock-based compensation 1,460   1,460    
Exercise of warrants (in shares)   346,809      
Exercise of warrants 987 $ 1 986    
Net loss (7,498)     (7,498)  
Foreign currency translation adjustment, net of tax $ 16       16
Balance (in shares) at Jun. 30, 2019 28,329,870 28,329,870      
Ending Balance at Jun. 30, 2019 $ 12,156 $ 28 $ 119,336 $ (107,199) $ (9)